XBiotech
XBIT
XBIT
48 hedge funds and large institutions have $59.3M invested in XBiotech in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
-1
Holders Change %
-2.04%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
16
Reduced
16
Closed
5
Calls
$2.9M
Puts
$3.29M
Net Calls
-$397K
Net Calls Change
+$30K
Top Buyers
| 1 |
BlackRock
New York
|
$21.3M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
$1.07M |
| 3 |
CIA
Capital Impact Advisors
Boston,
Massachusetts
|
$862K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
$12.3M |
| 5 |
Goldman Sachs
New York
|
$1.63M |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$503K |
| 2 |
Morgan Stanley
New York
|
$444K |
| 3 |
Citigroup
New York
|
$1K |
| 4 |
SO
STRS Ohio
Columbus,
Ohio
|
$65K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
$623K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Group One Trading
Chicago,
Illinois
| – | -$23K | -2,279 | Closed |
|
|
TRCT
52
Tower Research Capital (TRC)
New York
| – | -$6K | -610 | Closed |
|
|
AIM
53
Acrospire Investment Management
Chicago,
Illinois
| – | -$2K | -200 | Closed |
|